Read More Pharma Industry News What NPX-5’s Phase IIb trial means for the future of oncology-linked mental health treatments NPX-5 enters Phase IIb trials for cancer-related mental health. Discover what this means for biotech strategy, regulation, and future treatments. bySoujanya RaviApril 25, 2026